Prosecution Insights
Last updated: October 04, 2026

Incept LLC

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Incept LLC currently manages 7 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 4 distinct art units, indicating a portfolio that spans several specialized technical classifications. The involvement of 6 distinct examiners suggests that the company's prosecution strategy requires navigating a variety of individual examiner preferences and styles across these different units.

BOUCHELLE, LAURA A is identified as the busiest examiner for this portfolio, currently handling 2 pending office actions. This concentration represents a portion of the 7 total actions, making her specific examination patterns influential for the portfolio's overall progress. The remaining actions are spread among 6 distinct examiners, requiring a broad approach to examiner engagement across the 4 art units. Practitioners should consider the specific technical requirements of the art units when drafting responses, as the standards for patentability may vary across these specialized mechanical and medical fields.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
5
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (17%)
4
Medium (67%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
§112 only1 (17%)
Double-patenting + other1 (17%)
Multi-statute (no §101)1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
67% of docket
1
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOUCHELLE, LAURA A 2 80.2% +10.7%
HAGOPIAN, CASEY SHEA 1 54.4% +33.3%
PATEL, AREN 1 77.6% +17.2%
GABR, MOHAMED GAMIL 1 80.5% +21.9%
RIVERS, LINDSEY RAE 1 64.1% +56.9%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18317686 RETRIEVAL APPARATUS AND METHODS FOR USE GABR, MOHAMED GAMIL 30d overdue
18757118 CATHETER HAVING ANGLED TIP BOUCHELLE, LAURA A —

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18584895 EMBOLIZATION WITH TRANSIENT MATERIALS BOUCHELLE, LAURA A —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17036258 EMBOLIC RETRIEVAL CATHETER RIVERS, LINDSEY RAE 89d overdue
18317686 RETRIEVAL APPARATUS AND METHODS FOR USE GABR, MOHAMED GAMIL 30d overdue
18479324 METHODS AND APPARATUS FOR TREATING NEUROVASCULAR VENOUS OUTFLOW OBSTRUCTION PATEL, AREN 10d overdue
18757118 CATHETER HAVING ANGLED TIP BOUCHELLE, LAURA A —
18617246 DEVICES FOR IN SITU FORMED NERVE CAPS AND/OR NERVE WRAPS HAGOPIAN, CASEY SHEA —
18584895 EMBOLIZATION WITH TRANSIENT MATERIALS BOUCHELLE, LAURA A —

Top Art Units

Art UnitApps
3771 2
1617 1
3783 1
3774 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18757118 CATHETER HAVING ANGLED TIP BOUCHELLE, LAURA A — §112DP Non-Final OA — Pending Jun 27, 2024
18617246 DEVICES FOR IN SITU FORMED NERVE CAPS AND/OR NERVE WRAPS HAGOPIAN, CASEY SHEA 1617 §112 Non-Final OA — Pending Mar 26, 2024
18584895 EMBOLIZATION WITH TRANSIENT MATERIALS BOUCHELLE, LAURA A 3783 §103§112 Non-Final OA — Pending Feb 22, 2024
18479324 METHODS AND APPARATUS FOR TREATING NEUROVASCULAR VENOUS OUTFLOW OBSTRUCTION PATEL, AREN 3774 §103 Non-Final OA 10d overdue Pending Oct 02, 2023
18317686 RETRIEVAL APPARATUS AND METHODS FOR USE GABR, MOHAMED GAMIL 3771 §103 Non-Final OA 30d overdue Pending May 15, 2023
17036258 EMBOLIC RETRIEVAL CATHETER RIVERS, LINDSEY RAE 3771 §103 Final Rejection 89d overdue Pending Sep 29, 2020

Managing Incept LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month